Accelerate the Development of Effective Immunology Treatments

Immunology clinical trials often target patients with complex, chronic conditions that are difficult to diagnose and treat. Identifying and enrolling eligible patients is challenging. Keeping them engaged throughout a trial even more so.

Immunological diseases are multifactorial, often caused by a combination of genetic, environmental, and lifestyle factors. Trials involve treatments that manipulate the immune system, which can potentially lead to serious side effects. As such, these diseases require innovative approaches.

As a leader in the rapidly evolving field of immunology, Clinical ink provides comprehensive solutions that streamline trials, enhance data collection, and enable efficient analysis. Our innovative tools empower researchers to gather accurate and reliable data, accelerating the development of effective immunology treatments.

Immunology trials at Clinical ink

Precision Medicine for Enhanced Outcomes

Precision medicine plays a crucial role in immunology trials, tailoring treatments to patients based on their characteristics, biomarkers, and genetic factors. By identifying specific patient subgroups, researchers can optimize treatment strategies and improve outcomes.

With real-time data collection and monitoring, Clinical ink solutions drive personalized insights, reduce adverse events, and pave the way for a more effective approach to immunology care.

Powering Your Immunology Trials

Data Capture

Efficiently capture and manage complex data sets with eSource technology to ensure accurate and timely information

Patient Safety

Real-time monitoring enables prompt intervention for adverse events and complications


Promote effective communication, data sharing, and streamlined workflows for research teams

Patient Engagement

Improve patient satisfaction by reducing data collection burdens and facilitating easier communication

Simplify Every Step of Your Immunology Trials

Collecting quality data for immunology clinical trial data analysis is problematic—so much so that only one therapy has ever been approved for Systemic Lupus Erythematosus (SLE) to date.

The Clinical ink electronic Lupus Assessment Suite (eLAS®) is transforming lupus clinical trials as the the industry’s first scalable data capture system. Our eSource technology simplifies every step from pre-programmed workflows and comprehensive training to accessible patient charts, while real-time data and assessment access enhance medical review and adjudication. Experience the forefront of innovation with Clinical ink solutions that optimize your immunology trials.

Immunology clinical trial data analysis

Clinical trials for lupus treatment are a vital part of lupus research and assessment, but these trials are affected by extensive documentation requirements. Technology offers a solution.

Scroll to Top